logo

Against Monopoly

defending the right to innovate

innovation

Monopoly corrupts. Absolute monopoly corrupts absolutely.





Copyright Notice: We don't think much of copyright, so you can do what you want with the content on this blog. Of course we are hungry for publicity, so we would be pleased if you avoided plagiarism and gave us credit for what we have written. We encourage you not to impose copyright restrictions on your "derivative" works, but we won't try to stop you. For the legally or statist minded, you can consider yourself subject to a Creative Commons Attribution License.


back

The Age of Technocide: RIM Pays Out Again Over Patents

I previously noted that NTP used the patent system to wring over $600M out of RIM, the manufacturer of the Blackberry smartphone. As noted by Mike Masnick, now RIM has coughed up another quarter billion dollars to another company, Visto ("coincidentally" a licensee of NTP). A quarter billion dollars--everyone yawns. Masnick asks, why did NTP have to pay Visto?
For being the loser in the market place. This is a tax on innovation. The loser in the marketplace forces the winner to hand over a nice chunk of profits. It's bad for everyone (except some lawyers and Visto shareholders).
Masnick is right: this is yet another tax on innovation. Patents are killing innovation (see Yet Another Study Finds Patents Do Not Encourage Innovation). This is the age of technocide.

[Masnick opined that one reason NTP invested in Visto to get it to take out an NTP license was: "That certainly looks like NTP paying a company to license its patents, just to make it looks like there were some legitimate licensees."

This may be right, but as I explain in "Impact of Patent Licensing on Patent Litigation and Patent Office Proceedings" (available on my legal site), "a license under the patent may be offered as persuasive evidence in rebutting a prima facie case for obviousness." In other words, one reason patentees seek to license their patents is to build up the case that the patent is not obvious--to use it in litigation later to help defend the patent.]

[Mises cross-post; SK cross-post]


Comments

That is precisely the reason for the Microsoft-Novell patent cross license agreement. The agreement is intended to circumvent the GPLv2, the open source license for the Linux Kernel. While on the one hand circumventing the requirements that upstream rights must be transferred to the downstream recipients, the MS-NV agreement only protects customers, not developers.

But the agreement serves another purpose: to validate patents owned by Microsoft.

You can read about that agreement here: Patent Cooperation Agreement.

Scott Dunn


Submit Comment

Blog Post

Name:

Email (optional):

Your Humanity:

Prove you are human by retyping the anti-spam code.
For example if the code is unodosthreefour,
type 1234 in the textbox below.

Anti-spam Code
SevenEightUnoThree:


Post



   

Most Recent Comments

A Texas Tale of Intellectual Property Litigation (A Watering Hole Patent Trolls) Aunque suena insignificante, los números son alarmantes y nos demuestran que no es tan mínimo como

James Boyle's new book with his congenial IP views free to download

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1

French firm has patents on using computers to choose medical treatment 1